SCHEMBL4704409

SCHEMBL4704409

O=c1[nH]c2cc(Cl)c(Cl)cc2n(O)c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 8/20 0.64
GRIA2 P42262 8/20 0.64
GRIA3 P42263 8/20 0.64
GRIA4 P48058 8/20 0.64
GRIN2D O15399 6/20 0.58
GRIN3B O60391 6/20 0.58
GRIN1 Q05586 6/20 0.58
GRIN2A Q12879 6/20 0.58
GRIN2B Q13224 6/20 0.58
GRIN2C Q14957 6/20 0.58
GRIN3A Q8TCU5 6/20 0.58
MEN1 O00255 2/20 0.52
LMNA P02545 2/20 0.52
CYP1A2 P05177 2/20 0.52
TSHR P16473 2/20 0.52
BLM P54132 2/20 0.52
PMP22 Q01453 2/20 0.52
KMT2A Q03164 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9365335 0.82 GRIA1 (0.45) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9364672 0.82 GRIA1 (0.45) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9364598 0.79 DAO (0.70) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9395793 0.79 CA12 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL29212232 0.78 GRIA1 (1.00) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL4704910 0.78 GRIA1 (0.64) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9364622 0.78 GRIN2D (0.58) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9365357 0.75 GRIN2D (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL22292503 0.74 GRIA1 (0.63) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9368432 0.74 GRIN2D (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647137-B1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF UNIV CALIFORNIA (US) 2008-08-13 EP disclosed
US-5622952-A NERVOUS SYSTEM DISORDERS; ADMINISTERING 1,4-DIHYDROQUINOXALINE-2,3-DIONE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-22 US disclosed
US-5620979-A TREATING NEURONAL LOSS ASSOCIATED WITH STROKE, ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA OR SURGERY STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-15 US disclosed
US-5514680-A ANTICONVULSANTS WITH 5,6,7-TRISUBSTITUTED-1,4-DIHYDROQUINOXALINE-2,3-DIONE THE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY (US) 1996-05-07 US disclosed
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
WO-1994000124-A1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF WEBER ECKARD (US) 1994-01-06 WO disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed